Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition

被引:2
|
作者
Tortolini, Cristina [1 ]
Gigli, Valeria [1 ]
Rizzo, Flavio [1 ]
Lenzi, Andrea [1 ]
Bizzarri, Mariano [1 ]
Angeloni, Antonio [1 ]
Antiochia, Riccarda [2 ]
机构
[1] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Chem & Drug Technol, Piazzale Aldo Moro 5, I-00185 Rome, Italy
关键词
myo-inositol; D-chiro-inositol; biosensor; stereoselective recognition; voltammetric detection; MWCNTs; ENANTIOMERIC SEPARATION; ENANTIOSELECTIVE RECOGNITION; CAPILLARY-ELECTROPHORESIS; ELECTROCHEMICAL SENSOR; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; DRUGS; MEDIATORS; DISEASE; BINDING;
D O I
10.3390/s23229211
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This paper describes the development of a simple voltammetric biosensor for the stereoselective discrimination of myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) by means of bovine serum albumin (BSA) adsorption onto a multi-walled carbon nanotube (MWCNT) graphite screen-printed electrode (MWCNT-GSPE), previously functionalized by the electropolymerization of methylene blue (MB). After a morphological characterization, the enantioselective biosensor platform was electrochemically characterized after each modification step by differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy (EIS). The results show that the binding affinity between myo-Ins and BSA was higher than that between D-chiro-Ins and BSA, confirming the different interactions exhibited by the novel BSA/MB/MWCNT/GSPE platform towards the two diastereoisomers. The biosensor showed a linear response towards both stereoisomers in the range of 2-100 mu M, with LODs of 0.5 and 1 mu M for myo-Ins and D-chiro-Ins, respectively. Moreover, a stereoselectivity coefficient alpha of 1.6 was found, with association constants of 0.90 and 0.79, for the two stereoisomers, respectively. Lastly, the proposed biosensor allowed for the determination of the stereoisomeric composition of myo-/D-chiro-Ins mixtures in commercial pharmaceutical preparations, and thus, it is expected to be successfully applied in the chiral analysis of pharmaceuticals and illicit drugs of forensic interest.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology
    Bevilacqua, Arturo
    Carlomagno, Gianfranco
    Gerli, Sandro
    Oliva, Mario Montanino
    Devroey, Paul
    Lanzone, Antonio
    Soulange, Christophe
    Facchinetti, Fabio
    Di Renzo, Gian Carlo
    Bizzarri, Mariano
    Hod, Moshe
    Cavalli, Pietro
    D'Anna, Rosario
    Benvenga, Salvatore
    Chiu, Tony T.
    Kamenov, Zdravko A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (06) : 441 - 446
  • [22] Increased urinary excretion of myo-inositol and D-chiro-inositol in diabetes occurs independently of hyperglycaemia in the isolated perfused kidney
    Loomes, K. M.
    Choong, B.
    Phillips, A.
    Chang, H. -H.
    DIABETOLOGIA, 2011, 54 : S441 - S441
  • [23] The Role of myo-inositol/D-chiro-inositol in a physiological ratio of 40: 1 in preventing the onset of gestational diabetes mellitus
    Farren, M.
    Daly, N.
    McKeating, A.
    Turner, M. J.
    Daly, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (13) : E3 - E3
  • [24] Myo-Inositol and D-Chiro-Inositol Prevent Palmitate-induced Autophagy and Senescence in Human Cardiac Progenitor Cells
    D'Oria, Rossella
    Laviola, Luigi
    Leonardini, Anna
    Incalza, Maria Angela
    Caccioppoli, Cristina
    Nigro, Pasquale
    Scioscia, Marco
    Natalicchio, Annalisa
    Perrini, Sebastio
    Giorgino, Francesco
    DIABETES, 2015, 64 : A137 - A137
  • [25] Pregnancy Alters Urinary Excretion of Myo-Inositol and D-Chiro-Inositol.
    Murphy, Aisling
    Ma, Lina
    Shamshirsaz, Amir
    Ostlund, Richard E.
    Koos, Brian
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 310A - 310A
  • [26] Myo-inositol vs. D-chiro inositol in PCOS treatment
    Formuso, C.
    Stracquadanio, M.
    Ciotta, L.
    MINERVA GINECOLOGICA, 2015, 67 (04): : 321 - 325
  • [27] Metabolic and hormonal effects of a combined Myo-inositol and D-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS)
    Januszewski, Marcin
    Issat, Tadeusz
    Jakimiuk, Alicja A.
    Santor-Zaczynska, Malgorzata
    Jakimiuk, Artur J.
    GINEKOLOGIA POLSKA, 2019, 90 (01) : 7 - 10
  • [28] D-chiro-inositol and ovary
    Demaliaj, E.
    Bylykbashi, E.
    Cerekja, A.
    Hoxha, E.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2016, 38 (01): : 73 - 76
  • [29] Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
    Bevilacqua, Arturo
    Dragotto, Jessica
    Giuliani, Alessandro
    Bizzarri, Mariano
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 9387 - 9398
  • [30] Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome who undergo ICSI
    Llaneza, P.
    Aragon, M.
    Maldonado, V.
    Lorente, J.
    Bravo, M. J.
    Fonolla, J.
    Diaz, M. P.
    Olivares, M.
    Mendoza, N.
    HUMAN REPRODUCTION, 2018, 33 : 436 - 436